Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Keytruda
Australian Public Assessment Report
Device/Product Name
Keytruda
Active ingredients
Pembrolizumab
AusPAR Date
Published
Submission Number
PM-2020-06395-1-4
Submission Type
Extension of indication
Decision
Approved